More than 9 of 10 patients with cancer showed good immune response to the COVID-19 mRNA vaccines after receiving both doses, but subsets of high-risk patients did not, according to a new study.
Click here for original story, Study finds 94 percent of patients with cancer respond well to COVID-19 vaccines
Source: ScienceDaily